Terms: = Leukemia AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Clinical Outcome
529 results:
1. [The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia].
Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597
[No Abstract] [Full Text] [Related]
2. Incidence, risk factors, and outcome of asymptomatic central nervous system involvement in adult patients with acute myeloid leukemia.
Virijevic M; Kraguljac-Kurtovic N; Mitrovic M; Jakovic L; Bukumuric Z; Pantic N; Sabljic N; Pravdic Z; Cvetkovic M; Knezevic V; Dragovic-Ivancevic T; Djunić I; Rajic J; Milosevic V; Todorovic-Balint M; Vidovic A; Suvajdzic-Vukovic N
Hematol Oncol; 2024 Mar; 42(2):e3253. PubMed ID: 38536200
[TBL] [Abstract] [Full Text] [Related]
3. clinical Analysis of Pediatric Acute Megakaryocytic leukemia With CBFA2T3-GLIS2 Fusion Gene.
Du Y; Yang L; Qi S; Chen Z; Sun M; Wu M; Wu B; Tao F; Xiong H
J Pediatr Hematol Oncol; 2024 Mar; 46(2):96-103. PubMed ID: 38315896
[TBL] [Abstract] [Full Text] [Related]
4. Expression signature of ten small nuclear RNAs serves as novel biomarker for prognosis prediction of acute myeloid leukemia.
Zhang Z; Huang R; Lai Y
Sci Rep; 2023 Oct; 13(1):18489. PubMed ID: 37898705
[TBL] [Abstract] [Full Text] [Related]
5. Genetic Polymorphism Study of IDH 1/2 and TET2 Genes in Acute Myeloid leukemia Patients.
Atef M; Shafik NF; H A Hassan N; Allam RM; El-Meligui YM; Abdelaziz H
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3169-3182. PubMed ID: 37774069
[TBL] [Abstract] [Full Text] [Related]
6. BCR::ABL1 kinase domain mutation testing and clinical outcome in a nationwide chronic myeloid leukemia patient population.
Kockerols C; Valk PJM; Blijlevens NMA; Cornelissen JJ; Dinmohamed AG; Geelen I; Hoogendoorn M; Janssen JJWM; Daenen LGM; Reijden BAV; Westerweel PE
Eur J Haematol; 2023 Dec; 111(6):938-945. PubMed ID: 37731314
[TBL] [Abstract] [Full Text] [Related]
7. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions.
de Mendoza C; Rando A; Miró E; Pena MJ; Rodríguez-Avial I; Ortega D; González-Praetorius A; Reina G; Pintos I; Pozuelo MJ; Soriano V;
J Clin Virol; 2023 Oct; 167():105578. PubMed ID: 37660433
[TBL] [Abstract] [Full Text] [Related]
8. T-cell lymphoma patient harboring BCL11B mutations had favorable overall survival.
Chen C; Huang L; Liu S; Jiang X; Chen F; Wei X; Guo H; Zeng X; Zeng C; Przybylski GK; Li W; Li Y
Asia Pac J Clin Oncol; 2024 Feb; 20(1):81-86. PubMed ID: 37635422
[TBL] [Abstract] [Full Text] [Related]
9. Characteristics and outcome of infectious complications after autologous hematopoietic cell transplantation in multiple myeloma patients.
Jandial A; Lad D; Jain A; Khadwal A; Singh C; Prakash G; Suri V; Sreedharanunni S; Sachdeva MUS; Ray P; Varma N; Varma S; Malhotra P
Transpl Infect Dis; 2023 Oct; 25(5):e14123. PubMed ID: 37573150
[TBL] [Abstract] [Full Text] [Related]
10. [Efficacy and safety of secondary allogeneic hematopoietic stem cell transplantation in 70 patients with recurrent hematologic malignancies after transplantation].
Han TT; Liu Y; Chen Y; Zhang YY; Fu HX; Yan CH; Mo XD; Wang FR; Wang JZ; Han W; Chen YY; Chen H; Sun YQ; Cheng YF; Wang Y; Zhang XH; Huang XJ; Xu LP
Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):458-464. PubMed ID: 37550200
[No Abstract] [Full Text] [Related]
11. clinical outcome of therapy-related acute myeloid leukemia patients. Real-life experience in a University Hospital and a Cancer Center in France.
Belhabri A; Heiblig M; Morisset S; Vila L; Santana C; Nicolas-Virelizier E; Hayette S; Tigaud I; Plesa A; Labussiere-Wallet H; Sobh M; Michallet AS; Marie B; Nicolini FE; Guillermin Y; Gaëlle F; Lebras L; Rey P; Jauffret-Bertholon L; Laude MC; Sandrine L; Michallet M
Cancer Med; 2023 Aug; 12(16):16929-16944. PubMed ID: 37548369
[TBL] [Abstract] [Full Text] [Related]
12. Association of CYP1A1 T3801C (rs4646903) variant with the susceptibility and progression of B-chronic lymphocytic leukemia (B-CLL) in the Egyptian population.
Al-Adl M; El-Said A; El-Sebaie A; Refaat S; Youssef MM
Gene; 2023 Oct; 883():147673. PubMed ID: 37506988
[TBL] [Abstract] [Full Text] [Related]
13. clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression).
Scheubeck G; Jiang L; Hermine O; Kluin-Nelemans HC; Schmidt C; Unterhalt M; Rosenwald A; Klapper W; Evangelista A; Ladetto M; Jerkeman M; Ferrero S; Dreyling M; Hoster E
Leukemia; 2023 Sep; 37(9):1887-1894. PubMed ID: 37495776
[TBL] [Abstract] [Full Text] [Related]
14. Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial.
Schubert ML; Schmitt A; Hückelhoven-Krauss A; Neuber B; Kunz A; Waldhoff P; Vonficht D; Yousefian S; Jopp-Saile L; Wang L; Korell F; Keib A; Michels B; Haas D; Sauer T; Derigs P; Kulozik A; Kunz J; Pavel P; Laier S; Wuchter P; Schmier J; Bug G; Lang F; Gökbuget N; Casper J; Görner M; Finke J; Neubauer A; Ringhoffer M; Wolleschak D; Brüggemann M; Haas S; Ho AD; Müller-Tidow C; Dreger P; Schmitt M
J Hematol Oncol; 2023 Jul; 16(1):79. PubMed ID: 37481608
[TBL] [Abstract] [Full Text] [Related]
15. Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML).
Pohlmann A; Bentgens E; Schülke C; Kuron D; Reicherts C; Marx J; Angenendt L; Mikesch JH; Lenz G; Stelljes M; Schliemann C
Ann Hematol; 2023 Sep; 102(9):2543-2553. PubMed ID: 37428201
[TBL] [Abstract] [Full Text] [Related]
16. Estimating prognostic relevant cutoff values for a multiplex PCR detecting BCR::ABL1 in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy in resource-limited settings.
Hailu S; Kinde S; Cross M; Tsegaye A; Kelemu T; Seifu D; Alemayehu D; Tarekegn A; Jabessa G; Abeje D; Abebe M; Sherif A; Tadesse F; Platzbecker U; Howe R; Gebremedhin A
Ann Hematol; 2023 Jul; 102(7):1723-1729. PubMed ID: 37212909
[TBL] [Abstract] [Full Text] [Related]
17. clinical Analysis of Pediatric T-Cell Acute Lymphoblastic leukemia Using the MRD-Oriented Strategy System.
Xue YJ; Wang Y; Lu AD; Jia YP; Zuo YX; Ding MM; Zeng HM; Zhang LP
Clin Lymphoma Myeloma Leuk; 2023 Jul; 23(7):477-483. PubMed ID: 37080879
[TBL] [Abstract] [Full Text] [Related]
18. Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid leukemia.
Eriksson A; Engvall M; Mathot L; Österroos A; Rippin M; Cavelier L; Ladenvall C; Baliakas P
Clin Cancer Res; 2023 Aug; 29(15):2826-2834. PubMed ID: 37022349
[TBL] [Abstract] [Full Text] [Related]
19. Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study.
Lazzarotto D; Tanasi I; Vitale A; Piccini M; Dargenio M; Giglio F; Forghieri F; Fracchiolla N; Cerrano M; Todisco E; Papayannidis C; Leoncin M; Defina M; Guolo F; Pasciolla C; Delia M; Chiusolo P; Mulè A; Candoni A; Bonifacio M; Pizzolo G; Foà R
Ann Hematol; 2023 May; 102(5):1099-1109. PubMed ID: 36959485
[TBL] [Abstract] [Full Text] [Related]
20. Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.
Sauta E; Robin M; Bersanelli M; Travaglino E; Meggendorfer M; Zhao LP; Caballero Berrocal JC; Sala C; Maggioni G; Bernardi M; Di Grazia C; Vago L; Rivoli G; Borin L; D'Amico S; Tentori CA; Ubezio M; Campagna A; Russo A; Mannina D; Lanino L; Chiusolo P; Giaccone L; Voso MT; Riva M; Oliva EN; Zampini M; Riva E; Nibourel O; Bicchieri M; Bolli N; Rambaldi A; Passamonti F; Savevski V; Santoro A; Germing U; Kordasti S; Santini V; Diez-Campelo M; Sanz G; Sole F; Kern W; Platzbecker U; Ades L; Fenaux P; Haferlach T; Castellani G; Della Porta MG
J Clin Oncol; 2023 May; 41(15):2827-2842. PubMed ID: 36930857
[TBL] [Abstract] [Full Text] [Related]
[Next]
